Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
08/2000
08/03/2000WO2000032175A3 METHODS AND COMPOSITIONS FOR RESTORING CONFORMATIONAL STABILITY OF A PROTEIN OF THE p53 FAMILY
08/03/2000WO2000027850A3 Crf receptor antagonists and methods relating thereto
08/03/2000WO2000023471A3 Use of a cytokine-producing lactococcus strain to treat colitis
08/03/2000WO2000023407A3 Ureido-thiobutyric acid derivatives as ppar-agonists
08/03/2000WO2000020421A3 TRICYCLIC Δ3-PIPERIDINES AS α2-ANTAGONISTS
08/03/2000WO2000009549A9 Peripheral-type benzodiazepine receptor associated proteins, cloning, expression and methods of use
08/03/2000WO2000006589A9 Prostate derived ets factor
08/03/2000WO2000006185A3 Methods of using lanreotide, a somatostatin analogue
08/03/2000DE19903095A1 Gewinnung von gamma-Linolensäure aus Protozoen der Gattung Colpidium Production of gamma-linolenic acid from protozoa of the genus Colpidium
08/03/2000CA2361518A1 Purine inhibitors of cyclin dependent kinase 2 and ikb-.alpha.
08/03/2000CA2361516A1 Aminoalkylbenzofurans as serotonin (5-ht(2c)) agonists
08/03/2000CA2360690A1 Plasminogen kringle 4 region fragments and methods of use
08/03/2000CA2360687A1 Composition and method for treating diabetes
08/03/2000CA2360674A1 2-adamantanemethanamine compounds for treating abnormalities in glutamatergic transmission
08/03/2000CA2360643A1 Transnasal transport/immunisation with highly adaptable carriers
08/03/2000CA2360064A1 Transcriptional regulation of the human beta3-adrenergic receptor gene
08/03/2000CA2359034A1 Pyrazino(aza)indole derivatives
08/03/2000CA2358967A1 Hesperitin pro-forms with enhanced bioavailability
08/03/2000CA2357735A1 Modulation of immune response by ribavirin
08/03/2000CA2356481A1 Heteroaryl acetylenic sulfonamide and phosphinic acid amide hydroxamic acid tace inhibitors
08/03/2000CA2356480A1 Acetylenic sulfonamide thiol tace inhibitors
08/03/2000CA2356345A1 Acetylenic beta-sulfonamido and phosphinic acid amide hydroxamic acid tace inhibitors
08/03/2000CA2356299A1 Acetylenic .alpha.-amino acid-based sulfonamide hydroxamic acid tace inhibitors
08/03/2000CA2356267A1 2,3,4,5-tetrahydro-1h-¬1,4|benzodiazepine-3-hydroxamic acid as matrix metalloproteinase inhibitors
08/03/2000CA2355735A1 Acetylenic ortho-sulfonamido and phosphinic acid amido bicyclic heteroaryl hydroxamic acids as tace inhibitors
08/03/2000CA2326741A1 The use of gastrin in the treatment of diabetes
08/03/2000CA2325887A1 Method for obtaining an oil that is rich in hydroxyoctadecadienoic fatty acids (hode) or the esters thereof from a mixture containing linoleic acid or the esters thereof
08/02/2000EP1024199A2 Recovery of gamma-linolenic acid from protozoa of the genus Colpidium
08/02/2000EP1023445A1 Cadherin derived growth factor and the application thereof
08/02/2000EP1023435A2 Novel lactic acid bacteria species
08/02/2000EP1023323A1 Novel vitamin d receptor related polypeptides, nucleic acid sequence encoding the same and uses thereof
08/02/2000EP1023314A1 Bile acid salts of metals with physiological action and the use thereof in therapy
08/02/2000EP1023273A1 Cyclohexane derivatives difunctionalised in 1,4 as ligands of 5t h1a receptors
08/02/2000EP1023269A1 Beta3-adrenoreceptor agonists, agonist compositions and methods of using
08/02/2000EP1023263A1 Novel vitamin d analogues
08/02/2000EP1023251A1 Vanadium complexes of monohydroxamates and pharmaceutical compositions comprising them
08/02/2000EP1023081A1 Use of recombinant human uteroglobin in treatment of inflammatory and fibrotic conditions
08/02/2000EP1023080A1 Ligand binding site of rage and uses thereof
08/02/2000EP1023067A2 The use of inhibitors of the renin-angiotensin system for the treatment of hypoxia or impaired metabolic function
08/02/2000EP1023066A1 Novel pyrazole and pyrazoline substituted compounds
08/02/2000EP1023063A1 INDENO 1,2-c]-, NAPHTHO 1,2-c]- AND BENZO 6,7]CYCLOHEPTA 1,2-c]PYRAZOLE DERIVATIVES
08/02/2000EP1023061A1 Somatostatin agonists
08/02/2000EP1023057A1 Use of thiazolidinediones for the treatment of hyperglycaemia
08/02/2000EP1023056A1 Use of thiazolidinediones for the treatment of hyperglycaemia
08/02/2000EP1023030A2 Method and bottle for infant feeding
08/02/2000EP0613373B1 Risedronate delayed-release compositions
08/02/2000CN1261879A Method for preparing substituted perhydroisoindole
08/02/2000CN1261877A 4-bromo or 4-iodo phenylamino benzhydroxamic acid derivatives and their use as MEK inhibitors
08/02/2000CN1261804A Pharmaceutical compositions comprising an aldose reductase inhibitor and an ACE inhibitor
08/02/2000CN1261801A Allelic polygene diagnosis of reward deficiency syndrome and treatment
08/02/2000CN1261793A Sertraline salts and substained-release dosage forms of sertraline
08/02/2000CN1261792A Gelatine encapsulated solution dosage forms of sertraline
08/02/2000CN1261791A Targeted liposomal constructs for diagnostic and therapeutic uses
08/02/2000CN1261539A Effective defatting traditional Chinese medicine
08/02/2000CN1055089C Intermediate of protein kinase C inhibitor and its preparation
08/02/2000CN1055012C Convalescence capsule for diabetics
08/01/2000US6096888 Anthracyclinone derivatives and their use in amyloidosis
08/01/2000US6096885 Exhibit agonist activity for cck-a receptors thereby enabling them to modulate the hormones gastrin and cholecystokinin in mammals.
08/01/2000US6096781 2-phenyl-1-benzothiophene derivatives are useful for treatment of osteoporosis and hyperlipemia
08/01/2000US6096778 α-ketoamide multicatalytic protease inhibitors
08/01/2000US6096773 Inhibitor of binding of integrin to its receptors, such as (vascular cell adhesion molecule-1) and fibronectin and useful for controlling the diseases induced by binding
08/01/2000US6096753 Substituted pyrimidinone and pyridone compounds and methods of use
08/01/2000US6096748 Pyrimidine compounds useful in treating cytokine mediated diseases
08/01/2000US6096745 Imidazolone anorectic agents: III. heteroaryl derivatives
08/01/2000US6096735 Benzoheterocyclic derivatives
08/01/2000US6096364 Method for lowering blood glucose level by the administration of bioflavonoid
08/01/2000US6096314 Peptides and pharmaceutical compositions comprising them
08/01/2000CA2209925C 5,6-diaryl-5,6,7,8-tetrahydronaphthalenes and their analogs as estrogen agonists/antagonists
08/01/2000CA2189250C Cytokine regulatory agents and methods of use in pathologies and conditions associated with altered cytokine levels
08/01/2000CA2158058C Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof
08/01/2000CA2121571C Substituted phenoxy isobutyric acids and esters
08/01/2000CA2006322C Recombinant dna molecules, hosts, processes and human somatomedin carrier protein-like polypeptides
07/2000
07/29/2000CA2260397A1 Method of converting rendered triglyceride oil from marine sources into bland, stable food oil
07/27/2000WO2000043781A2 Growth differentiation factor inhibitors and uses therefor
07/27/2000WO2000043495A2 33 human secreted proteins
07/27/2000WO2000043419A2 Exocytosis pathway proteins and methods of use
07/27/2000WO2000043415A1 Compounds which inhibit leukocyte adhesion mediated by vla-4
07/27/2000WO2000043414A1 Tripeptide compounds useful as selective inhibitors of aminopeptidase a and corresponding pharmaceutical compositions
07/27/2000WO2000043413A2 Pyroglutamic acid derivatives and related compounds which inhibit leukocyte adhesion mediated by vla-4
07/27/2000WO2000043407A1 Remedies
07/27/2000WO2000043393A1 Novel angiogenesis inhibitors
07/27/2000WO2000043384A1 Aromatic heterocyclic compounds as antiinflammatory agents
07/27/2000WO2000043378A1 New morpholinobenzamide salts
07/27/2000WO2000043373A2 Kinase inhibitors
07/27/2000WO2000043371A2 Fused ring heteroaryl and heterocyclic compounds which inhibit leukocyte adhesion mediated by vla-4
07/27/2000WO2000043354A2 Multicyclic compounds which inhibit leukocyte adhesion mediated by vla-4
07/27/2000WO2000043058A1 Method of enhancing needleless transdermal powdered drug delivery
07/27/2000WO2000043036A2 Lipoprotein complexes and compositions containing them
07/27/2000WO2000043035A1 Amino acid-containing albumin preparations
07/27/2000WO2000043034A2 Monodisperse hexameric acylated insulin analog formulations
07/27/2000WO2000043020A1 Egg anti-inflammatory composition and method of treating and preventing inflammation
07/27/2000WO2000043019A2 Egg anti-inflammatory composition and method of treating and preventing inflammation
07/27/2000WO2000043018A1 Medicinal compositions
07/27/2000WO2000043016A1 DICARBA-closo-DODECABORANE DERIVATIVES
07/27/2000WO2000043013A1 Pharmaceutical compositions for alleviating discomfort
07/27/2000WO2000042868A1 Infant formula
07/27/2000WO2000027832A3 Thiazole derivatives as ppar gamma ligands
07/27/2000WO2000018915A3 Membrane-associated organizational proteins
07/27/2000WO2000017328A3 Fibrils
07/27/2000WO2000011171A3 Human rna-associated proteins
1 ... 1099 1100 1101 1102 1103 1104 1105 1106 1107 1108 1109 1110 1111 1112 1113 1114 1115 1116 1117 1118 1119 ... 1298